Home Markets Amgen says experimental obesity drug has promising durability

Amgen says experimental obesity drug has promising durability

Dec 04, 2022 comments off

Original source: https://www.investing.com/news/stock-market-news/amgen-says-experimental-obesity-drug-has-promising-durability-2956824

You May Also Like

Rupert Murdoch’s News Corp to sell Foxtel to Britain’s DAZN for $2.1 billion

Westpac admits to overcharging more than 24,000 customers in New Zealand

Malaysia’s 1MDB files legal claim against Amicorp Group seeking over $1 billion for alleged fraud 

Honda, Nissan set to announce launch of integration talks, sources say

Singapore’s TalkMed shares jump on $447 million privatization offer

Asia stocks rise on US inflation cheer; Honda-Nissan merger in focus